Tectonic Therapeutic, Valuation
| TECX Stock | 40.16 3.71 8.46% |
At this time, the company appears to be undervalued. Tectonic Therapeutic, has a current Real Value of USD50.6 per share. The regular price of the company is USD40.16. Our model measures the value of Tectonic Therapeutic, from inspecting the company fundamentals such as Shares Owned By Institutions of 43.43 %, current valuation of 83.39 M, and Price To Book of 1.59 X as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Tectonic Therapeutic,'s price fluctuation is very steady at this time. Calculation of the real value of Tectonic Therapeutic, is based on 3 months time horizon. Increasing Tectonic Therapeutic,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Tectonic Therapeutic, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tectonic Stock. However, Tectonic Therapeutic,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 40.16 | Real 50.6 | Hype 39.22 | Naive 40.6 |
The intrinsic value of Tectonic Therapeutic,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tectonic Therapeutic,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tectonic Therapeutic, helps investors to forecast how Tectonic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tectonic Therapeutic, more accurately as focusing exclusively on Tectonic Therapeutic,'s fundamentals will not take into account other important factors: Tectonic Therapeutic, Total Value Analysis
Tectonic Therapeutic, is at this time forecasted to have valuation of 83.39 M with market capitalization of 265.07 M, debt of 4.34 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Tectonic Therapeutic, fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
83.39 M | 265.07 M | 4.34 M |
Tectonic Therapeutic, Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Tectonic suggests not a very effective usage of assets in January.Tectonic Therapeutic, Ownership Allocation
The market capitalization of Tectonic Therapeutic, is USD265.07 Million. Tectonic Therapeutic, maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Tectonic Therapeutic, Profitability Analysis
Net Loss for the year was (42.82 M) with profit before overhead, payroll, taxes, and interest of 0.About Tectonic Therapeutic, Valuation
Our relative valuation model uses a comparative analysis of Tectonic Therapeutic,. We calculate exposure to Tectonic Therapeutic,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tectonic Therapeutic,'s related companies.Tectonic Therapeutic, Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 3.7 M |
Additional Tools for Tectonic Stock Analysis
When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.